XML 77 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated balance sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Non-current assets [abstract]    
Property, plant and equipment $ 10,764 $ 11,545
Right-of-use assets 1,431 1,561
Goodwill 29,301 29,595
Intangible assets other than goodwill 31,644 34,182
Investment in associated companies 143 205
Deferred tax assets 3,739 3,743
Financial assets 2,411 3,036
Other non-current assets 1,110 2,210
Total non-current assets 80,543 86,077
Current assets [abstract]    
Inventories 7,175 6,666
Current trade receivables 8,066 8,005
Income tax receivable 268 278
Marketable securities, commodities, time deposits and derivative financial instruments 11,413 15,922
Cash and cash equivalents 7,517 12,407
Other current assets 2,471 2,440
Total current assets 36,910 45,718
Total assets 117,453 131,795
Equity [abstract]    
Share capital 890 901
Treasury shares (92) (48)
Reserves 58,544 66,802
Equity attributable to Novartis AG shareholders 59,342 67,655
Non-controlling interests 81 167
Total equity 59,423 67,822
Non-current liabilities [abstract]    
Financial debts 20,244 22,902
Lease liabilities 1,538 1,621
Deferred tax liabilities 2,686 3,070
Provisions and other non-current liabilities 4,906 6,172
Total non-current liabilities 29,374 33,765
Current liabilities [abstract]    
Trade payables 5,146 5,553
Financial debts and derivative financial instruments 5,931 6,295
Lease liabilities 251 275
Current income tax liabilities 2,533 2,415
Provisions and other current liabilities 14,795 15,670
Total current liabilities 28,656 30,208
Total liabilities 58,030 63,973
Total equity and liabilities $ 117,453 $ 131,795